NVRO's logo.
Ticker Symbol: NVRO

Nevro Corp

$95.51 - 20-12-2024 4 p.m. ET

Exchange: NEW YORK STOCK EXCHANGE INC. Country: US Currency: USD Asset Type: Common Stock CIK:0001444380

Company Profile

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in =65% of patients across six peer-reviewed clinical studies. The Senza® System, Senza II™ System, and the Senza® Omnia™ System are the only SCS systems that deliver Nevro's proprietary HF10® therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 1800 Bridge Pkwy
Website: www.nevro.com
CEO: D.Keith Grossman
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $18.80
Change: -$0.52 ( -2.69%)
Days Range: $18.75 - $19.32
Beta: 1.15
52wk. High: $48.10
52wk. Low: $15.91
Ytd. Change -53.88%
50 Day Moving Average: $18.97
200 Day Moving Average: $24.25
Shares Outstanding: 36120122

Valuation

Market Cap: 67.9B
PE Ratio: 262.71
EPS (TTM): 0.0716

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A